Acet Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acet Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acet Capital Today - Breaking & Trending Today

Simmunome secures $2 million to make clinical trials more efficient with AI

Published: September 18, 2023

Using artificial intelligence, Montréal-based Simmunome aims to help predict whether drug candidates will succeed or fail in clinical trials.

Source: betakit.com

Related Topics:

United StatesArmstrong MuriraNardin NakhlaTheodorus InvestmentSandpiper VenturesFront Row VenturesAltis LabsDeep GenomicsValence DiscoveryFondsd Investissement EurêkaBkr CapitalAcet CapitalClinical Trials